NCT07913061
A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin
StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Change in Glycated Hemoglobin A1c (HbA1c) (Non-inferiority)
Timeframe: From baseline to Week 26.
Secondary (2)
Hypoglycemia Event Rate during the treatment period
Adverse events (AEs)
Arms and interventions
SHR-3167 GroupExperimental
SHR-3167.
Insulin Degludec GroupActive comparator
Insulin degludec.
Drugs: SHR-3167, insulin degludec
Sites
2 sites in 1 country